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The Human Embryo, but Not Its Yolk Sac, Generates
Lympho-Myeloid Stem Cells: Mapping Multipotent
Hematopoietic Cell Fate in Intraembryonic Mesoderm
pressing markers of hematopoietic progenitors are in-
deed present in the mouse embryonic dorsal aorta (Gar-
cia-Porrero et al., 1995, 1998; Wood et al., 1997; North
et al., 1999; Petrenko et al., 1999).
In the human embryo, we have previously identified
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2 INSERM U362 a dense population of blood cells adhering to the ventral
side of the aortic endothelium that exhibits surface anti-Institut Gustave Roussy
94805 Villejuif Cedex gens and expresses genes that typify primitive progeni-
tors (Tavian et al., 1996; Labastie et al., 1998; Watt et al.,France
2000). Hematopoietic cell clusters appear in the aorta
at precisely 27 days of gestation, before the incipience
of hepatic hematopoiesis. This timely emergence sug-Summary
gested a pivotal role for intraembryonic precursors in
the colonization of the liver and therefore in the estab-We have traced emerging hematopoietic cells along
lishment of human definitive hematopoiesis (Tavian ethuman early ontogeny by culturing embryonic tissue
al., 1999). Initiation of a hematopoietic cell differentiationrudiments in the presence of stromal cells that promote
program from human intraembryonic tissue has alsomyeloid and B cell differentiation, and by assaying
been suggested by the expression, in the region underly-T cell potential in the NOD-SCID mouse thymus. He-
ing the dorsal aorta, of bone morphogenetic protein 4,matogenous potential was present inside the embryo
known to induce ventral mesoderm (Marshall et al.,as early as day 19 of development in the absence of
2000). Altogether, these results provided circumstantialdetectable CD34 hematopoietic cells, and spanned
evidence to indicate the existence of a blood-formingboth lymphoid and myeloid lineages from day 24 in the
potential intrinsic to the human intraembryonic splanch-splanchnopleural mesoderm and derived aorta where
nopleura. Indeed, ventral truncal territories dissectedCD34 progenitors appear at day 27. By contrast, he-
away from the human embryo and cultured on bonematopoietic cells arising in the third week yolk sac,
marrow stroma produced myeloid blood cells for 4–5as well as their progeny at later stages, were restricted
weeks (Tavian et al., 1999). However, the earliest embryoto myelopoiesis and therefore are unlikely to contrib-
cultured in these experiments was 24 days old, that is,ute to definitive hematopoiesis in man.
blood had been circulating for about 3 days and hence
had possibly disseminated yolk sac-derived blood cellIntroduction
progenitors inside the embryo tissues.
In order to decipher the very origin of human HSC,All blood cells are generated from a small cohort of
we describe here the analysis of human intra- and extra-pluripotent hematopoietic stem cells (HSC) through de-
embryonic tissues before and after they have been con-velopmentally restricted progenitors which undergo lin-
nected by the vascular tree. By virtue of a bone marroweage commitment and subsequent differentiation along
stromal cell line permissive for simultaneous myeloida single pathway (for review, see Morrison et al., 1995).
and B-lymphoid development (Berardi et al., 1997; RobinIt was long assumed that during development in
et al., 1999a) and in combination with xenogenic fetalhigher vertebrates, the yolk sac (YS), which is the first
thymus organ cultures (Robin et al., 1999b), we assessedblood-forming tissue, was also the unique provider of
the lineage commitment of intra- and extraembryonicHSC, no intrinsic hematopoietic potential having been
hematopoietic cells. We demonstrate that the human yolkfound in any other tissue inside the embryo (Moore and
sac generates only progenitors with limited develop-Metcalf, 1970). However, experiments in birds later dem-
mental potential, whereas multilineage lympho-myeloidonstrated that definitive hematopoiesis stems from
progenitors emerge later and autonomously in the pre-precursors emerging in the embryo proper (Dieterlen-
sumptive aortic territory.Lie`vre, 1975). In birds, intraembryonic hematopoietic ac-
tivity is localized in a region neighboring the dorsal aorta,
Resultsunder and inside which blood cell progenitors have been
identified (for review, see Dieterlen-Lie`vre, 1994). The
The aim of this study was to describe the emergencehomologous territory in the mouse embryo, the aorta/
of hematopoietic cells inside the human embryo by as-gonad/mesonephros (AGM) region and its anlage, the
sessing the presence in selected territories of progeni-paraaortic splanchnopleura (P-Sp), are endowed with
tors establishing long-term (4–7 week) hematopoietichematopoietic potential (Godin et al., 1993; Medvinsky
cultures in vitro. Analysis was focused on the truncalet al., 1993; Medvinsky and Dzierzak, 1998). Cells ex-
splanchnopleura and derived aorta, gonad, and meso-
nephros. Matching yolk sac was analyzed in parallel
3 Correspondence: tavian@infobiogen.fr in each experiment. In a second phase, we compared4 Present address: INSERM U421, Faculte´ de Me´decine, Cre´teil,
intraembryonic hematopoietic progenitors with thoseFrance.
derived from the yolk sac in terms of myeloid and5 Present address: Department of Cell Biology and Genetics, Eras-
mus University, Rotterdam, The Netherlands. lymphoid differentiation potentials.
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Figure 1. Human Embryo Dissection and Culture
(A and B) The paraaortic splanchnopleura and aorta in 24 and 33 day human embryos, respectively, were dissected along the dotted lines.
(B) The AGM is dissected to separate the dorsal aorta (DA) and underlying mesoderm from the urogenital ridge (gonad, G; mesonephros, Mn;
mesentery, Mt). Arrow shows intraarterial hematopoietic cell clusters. S, somites; Nc, notochord; NT, neural tube; CV, cardinal vein.
(C) In vitro culture conditions used to detect myeloid, NK, B, and T cell potentialities in early human embryos. In some instances, CD34 cells
present in the dish at the end of the expansion culture (II) were sorted by flow cytometry prior to seeding into differentiation culture (III).
Hematopoietic Progenitors Are Detected in the (see the following section). The two earliest specimens
analyzed were at the 19th day of development, a presomiteEmbryo Proper as Early as Day 19 of Development
Human embryos ranging from 19 to 48 days were ana- stage at which gastrulation is not completely achieved
lyzed. From 21 to 26 days, we dissected the whole para-
aortic splanchnopleura (Figure 1A), including the dorsal
aortae which, at these early stages of development, are Table 1. Blood Cell Formation in Human Intra- and Extraembryonic
not yet fused. From day 27 onward, the single dorsal Territories Cultured in the Presence of MS-5 Stroma
aorta enclosed in a fine sheath of mesoderm (Figure Embryo age
1B) was cut apart with microdissection scissors and
Carnegie Somitesmicroscalpels from its anterior bifurcation to its caudal
stage Days (pairs) P-Sp/aorta# Yolk sacend after the vitelline artery connection (Tavian et al.,
8 19 0 *2/2 2/21999). Explants were first seeded intact for 1–2 days
9 21 1–3 1/1 1/1on monolayers of confluent murine MS-5 stromal cells,
10 22–23 4–12 5/5 5/5which allow the survival, proliferation, and lympho-myeloid
11 24–25 13–20 4/6 6/6
differentiation of human hematopoietic stem cells (Be- 12 26–27 21–29 11/14 12/12
rardi et al., 1997; Robin et al., 1999a). Tissues were then 13 28–30 30–35 5/7 5/5
dissociated by repeated pipetting inside the wells and 14 31–32 § 4/4 4/4
15 33–34 4/4 4/4cultured there for 7–10 additional days to amplify the
16 35–40 2/2 NDhematopoietic cell compartment (see protocol in Figure
17–19 40 0/2 ND1C). Only those wells containing a layer of confluent
Results are presented as the number of cultures that sustainedhematopoietic cells were further processed, by harvest-
hematopoiesis out of the total cocultures performed at each stage.ing and seeding the whole content of the well onto fresh
* At this stage, somites are not yet formed and gastrulation is probablyMS-5 stromal layers (the content of one well was gener-
not completely achieved. The whole embryo was placed in culture.
ally split into ten wells of a 96-well plate). Wells were # The P-Sp and aorta were dissected from the embryo from stage
checked for cell growth for 4–5 weeks and considered 9 to stage 12 and from stage 13 onward, respectively.
positive when containing, after 3 weeks, colonies of § From this stage on, the number of somites is no longer a reliable
staging criterion.packed rounded cells exhibiting the typical morphology
The embryonic stages when hematopoietic cell clusters are presentof hematopoietic cells. Results are shown in Table 1. In
inside the aorta and vitelline artery are set in bold italics.all instances, the hematopoietic identity of cells devel-
ND, not done; P-Sp, paraaortic splanchnopleura.
oping in the cocultures was confirmed by flow cytometry
Human Blood Stem Cell Ontogeny
489
Figure 2. Generation in Culture of CD34-Positive Hematopoietic Progenitors from the Embryo and Yolk Sac at a Presomite Stage (Day 19)
Cells growing on MS-5 stroma from the embryo (B and C) and yolk sac (E and F) were stained with anti-CD34-FITC. Analyses were performed
at days 14 (B and E) and 33 (C and F) of culture. Analyzed cells were first gated on forward/side scatter (A and D).
and the primitive streak can still be identified. The yolk In ten experiments in which the 24 to 34 day dissected
P-Sp/aorta was analyzed in this setting, CD34 cells gen-sac and embryo were separated and cultivated intact in
distinct wells for 10 days under the conditions described erated during the expansion phase of the culture (Figure
1C) were sorted by FACS prior to being further seededabove, and then dissociated and cells from each well
seeded into four wells on fresh stromal cells. into lympho-myeloid differentiation cultures. The number
of CD34 cells sorted from one well ranged from 100 toHematopoietic potential was present in the embryo
proper as early as day 19 (Table 1), as shown by the 700. The outcome was the same as when the whole
unsorted population was used (data not shown), indicat-development of colonies of rounded cells over the stro-
mal layer starting from day 7 of culture. The whole con- ing that the blood-forming activity observed in these ex-
periments correlates with the emergence of CD34 cells.tent of the wells was dissociated mechanically and cells
were analyzed by flow cytometry. Hematopoietic cells
could readily be distinguished from stromal cells and The P-Sp/Aorta, but Not the Yolk Sac, Produces
Both Lymphoid and Myeloid Cellsunrelated embryonic cells by virtue of morphological
traits (side scatter/forward scatter gate; Figures 2A We set out to evaluate the lineage commitment of hema-
topoietic progenitors emerging in the human P-Sp/aortaand 2D). That gate included CD34-positive cells, which
peaked in percentage after 2 weeks (Figure 2B) and and yolk sac, applying the protocol outlined in Figure
1C. In this setting, hematopoietic cells proliferate rapidlywere still detectable in the wells after day 33 (Figure 2C).
Since no hematopoietic CD34 cells are seen in the and are numerous enough to be analyzed after only 7
days of differentiation culture. At all stages studied fromintact human embryo before day 27 (Tavian et al., 1999),
these progenitors arose in the culture from earlier stem 19 to 40 days, cells from either the P-Sp/aorta or yolk
sac can generate NK (CD56) and granulomonocyticcells. At the same stage, the yolk sac was also hemato-
poietic, as expected since vitelline blood islands form (CD15) cells (Table 2; Figures 3A, 3B, and 3F). To further
ascertain that natural killer cells differentiate in thesefrom day 18.5 (Bloom and Bartelmez, 1940). In contrast
to embryo cultures, yolk sac-derived CD34 cells were conditions from extra- and intraembryonic hematopoi-
etic progenitors, cells grown in the same conditions onless numerous (Figure 2E), decreased rapidly in number,
and disappeared by 4 weeks of culture (Figure 2F). MS-5 stroma from a 26 day P-Sp, a 32 day aorta and
yolk sac, and a 36 day aorta were double stained withIntraembryonic hematogenous capacity was then reg-
ularly detected from 21 to 40 days of development, first antibodies to CD56 and CD94, a c-type lectin broadly
expressed on NK cells (Pende et al., 1997). In all in-in the paraaortic splanchnopleura, and then in the dis-
sected aorta (Table 1). After 40 days of gestation, hema- stances, subsets of CD56CD94 cells were detected
that accounted for 69%, 17%, 20%, and 34%, respec-topoietic cells proliferating from cultured dissected aor-
tae were less abundant and rapidly differentiated into tively of the whole CD56-expressing cell population (Fig-
ure 3C). Similarly, 24% of the CD56 cells developedlarge, scattered cells. Hematopoiesis established from
these older tissues did not persist longer than 10–15 days in the same conditions from cord blood CD34 cells
expressed CD94 (data not shown), confirming that CD94(data not shown). These results show that hematopoietic
progenitors, or their forerunners, emerge in the human expression is posterior to that of CD56 in the course of
NK cell development (Carayol et al., 1998).P-Sp/aorta from at least 19 days of gestation.
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Table 2. Lymphoid, Myeloid, and NK Cell Development from the Human P-Sp/Aorta and Yolk Sac
Embryo age Paraaortic splanchnopleura/aorta Yolk sac
Carnegie B M NK T B M NK T
stage Days CD19 CD15 CD56 CD4 CD19 CD15 CD56 CD4
8 19 0/2 2/2 2/2 ND 0/2 2/2 2/2 ND
9 21 0/1 1/1 1/1 ND 0/1 1/1 1/1 ND
10 22–23 0/5 5/5 5/5 0/1 0/4 4/4 4/4 0/1
11 24–25 3/4 4/4 3/4 ND 0/4 4/4 3/4 ND
12 26–27 7/11 11/11 11/11 3/8 0/10 10/10 9/9 0/7
13 28–30 5/7 7/7 7/7 3/4 0/5 5/5 5/5 0/2
14 31–32 2/3 3/3 4/4 2/4 0/3 3/4 3/4 0/4
15 33–34 3/3 3/3 3/3 ND 0/2 2/2 2/2 ND
16 35–40 1/1 1/1 2/2 ND ND ND ND ND
ND, not done.
CD19 B cells also differentiate in vitro from the in- of development, that is, shortly before the appearance
of intraarterial hematopoietic cell clusters, which arise attraembryonic region, albeit from 24 days of gestation
only (Table 2; Figures 3A, 3B, and 3F). B cells usually the 27th day of gestation (Tavian et al., 1999).
Altogether, these results show that, even in the vascu-appear during the third week of coculture, significantly
later than the other blood cell types, as previously ob- larized human embryo, lympho-myeloid stem cells are
confined to intraembryonic tissues but are absent fromserved for human HSC cultured on MS-5 cells (C.R.
and L.C., unpublished data). The percentage of B cells the yolk sac, as illustrated by grouped analyses of a 31
day specimen (Figure 3F).increases over the next week to reach up to 34% of the
cells analyzed (Figure 3B). B lymphocytes were often
still present after 40 days of culture (data not shown). In the Human AGM, Only the Aorta Contains
Hematopoietic ProgenitorsNo such capacity to produce B cells was ever found in
yolk sac cocultures (Table 2), from which CD19-positive The acronym AGM designates a large part of the embryo
trunk that encloses, beside the dorsal aorta and sur-cells were consistently very rare or absent at all stages
of development tested, including after the onset of blood rounding mesoderm, the rudiments of the kidneys and
gonads. In order to more accurately map hematopoieticcirculation between intra- and extraembryonic compart-
ments (Figures 3B and 3F). territories in the human embryo, the mesonephros/
gonads, aorta, and remainder of the embryo deprivedWe then tested the T cell potential of extra- and in-
traembryonic progenitors in 17 independent experi- of the liver were dissected separately and cultivated
individually under the above described conditions. Sixments. The P-Sp/aorta and YS cultured intact for 10 days
on MS-5 cells were dissociated and used to populate independent experiments carried out between 26 and
31 days of gestation show that in the human AGM, onlyorgan-cultured NOD-SCID mouse fetal thymuses (Fig-
ure 1C). Since the SCID mutation blocks T cell develop- the aorta encloses hematopoietic progenitors (Table 3;
Figure 4), as assessed by development in culture of B,ment, no removal of endogenous thymocytes was re-
quired (Robin et al., 1999b). Usually, five to ten thymic NK, and myeloid cells (Table 2).
lobes were seeded per tissue analyzed, and each lobe
was incubated with 50–100,000 total, unseparated do- Discussion
nor cells. Positive control thymuses were incubated with
2,000–5,000 cord blood-derived CD34 sorted cells. In Recent years have seen the appreciation of the key
role played by stem cells born inside the embryo in thethis setting, the ability to generate T lymphocytes was
restricted to P-Sp/aorta progenitors. Human CD4 sin- settlement of definitive hematopoiesis. We have partici-
pated in this reconsideration of the very origin of mam-gle-positive and CD4CD8 double-positive T lympho-
cytes were present in thymuses populated by human malian blood cells by describing the emergence of cell
clusters in the 5 week human embryo adhering to theintraembryonic progenitors, while yolk sac-derived cells
were always devoid of T cell potential (Figure 3D; Table ventral aortic endothelium and possessing phenotypic
and genetic characteristics of primitive hematopoietic2). Under these conditions, the production of single-
positive CD4CD8 T cells is compromised by the poor progenitors (Huyhn et al., 1995; Tavian et al., 1996; La-
bastie et al., 1998; Watt et al., 2000). The spatial andreactivity of mouse class I molecules with human cells
(Blom et al., 1997). It was not determined whether human temporal distribution of these progenitors during em-
bryogenesis suggests that they colonize the liver rudi-embryonic cells gave rise to other subsets of non-
lymphoid hematopoietic cells inside the murine thymus ment, implying their major role in the establishment of
the human blood system (Tavian et al., 1999). Indeed,environment. In the experiments carried out with P-Sp-
derived cells, the proportion of human CD4 cells inside these groups of CD34 hematopoietic cells first come
into existence on the 27th day of gestation, inside athe chimeric thymus was variable but always significant
(Figure 3E). Remarkably, within the same experiment, segment of the aorta which is just dorsal to the liver
rudiment, and only 2–3 days before hepatic colonizationeach individual lobe analyzed was populated with T cells.
The results reported in Table 2 indicate that T-lymphoid by CD34 progenitors (Tavian et al., 1999). At the stage
of stem cell emergence in the truncal arteries, though,potential emerges inside the embryo as early as day 26
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the yolk sac has already been producing blood cells for which produced only myeloid and NK cells. Therefore,
lympho-myeloid progenitors develop intrinsically in theabout 10 days (Bloom and Bartelmez, 1940); some of
these cells have disseminated inside the embryo, since human embryo. The mouse yolk sac was shown to har-
bor lympho-myeloid progenitors (Weissman et al., 1978)blood circulates from day 21 (Tavian et al., 1999). To
ascertain that the aorta-adherent CD34 hematopoietic and B cell precursors (Tyan and Herzenberg, 1968;
Ogawa et al., 1988; Palacios and Imhof, 1993; Huang etcells do not derive from blood-borne progenitors but
develop intrinsically to the vessel wall, the precirculation al., 1994; B.P., unpublished data) after 9 days of gesta-
tion, once connected to the embryo through blood ves-rudiment of the latter has been cultured in the presence
of MS-5 stromal cells, a suitable support for human sels. In contrast, Cumano et al. (1996) and B.P. (unpub-
lished data) failed to detect lymphoid potential in themultilineage hematopoiesis.
The presumptive ventral half of the aorta, including mouse yolk sac taken before 8.5 days, the stage at which
the yolk sac and embryo become connected throughendothelial cells and the surrounding mesoderm, is en-
closed in the splanchnopleura, while dorsal aortic endo- circulation. However, two reports have described the
presence of B cell (Palacios and Imhof, 1993) and T cellthelial cells stem from somitic mesoderm (Pardanaud
et al., 1996). As early as day 19 of development, 2 days precursors (Liu and Auerbach, 1991) in the yolk sac
dissected before 8.5 days, suggesting that appropriatebefore the onset of blood circulation, the embryo, dis-
sected away from the yolk sac, gives rise to CD34 and conditions may reveal multilineage hematopoietic po-
tential in stem cells emerging outside the mouse em-then to differentiated hematopoietic cells in culture. The
human embryo is therefore a site where hematopoietic bryo. In human ontogeny, we observed the most clear
cut difference between the embryo and yolk sac in termsstem cells are produced and not merely home and ad-
here. In line with these findings, molecular analysis of of hematopoietic potential. This may also reflect evolu-
tionary differences between the human embryo and thathuman and chicken embryos had previously shown in
the aortic region the expression of genes that mark the of other vertebrates. The human yolk sac might repre-
sent, phylogenetically, the most extreme reduction ofonset of hematopoietic development, such as SCL/
tal-1 and c-myb (Vandenbunder et al., 1989; Labastie extraembryonic blood-forming activity. Conversely, em-
bryonic intravascular stem cell clusters are larger in theet al., 1998). Messengers for these genes were solely
detected, on tissue sections, in the few hematopoietic human embryo than in chicken and mouse embryos.
Even though the human yolk sac does not produce lympho-cells that sprout from the ventral aortic endothelium,
which may explain why Palis et al. (1999) failed to detect myeloid progenitors de novo, such stem cells originating
in the aorta and carried by the blood stream should haveSCL and c-myb by PCR in the whole-mouse AGM. Yet,
totipotential hematopoietic progenitors also arise in the been identified in our assays, as occurred in mouse
embryo studies (Cumano et al., 1996). The observationmouse embryo proper prior to the onset of circulation
(Cumano et al., 1996), and are therefore unrelated to yolk that this was not the case may emphasize another differ-
ence between human and mouse hematopoiesis, thesac hematopoiesis. Thus, the human embryo contains
ancestral blood cell progenitors, arising at least 8 days former being characterized by reduced mobility of aorta-
derived multipotential progenitors. Along this line, webefore CD34 hematopoietic cells can be detected on
the aortic wall. The identity of these ancestors is not yet have previously observed that human circulating blood
at these embryonic stages is devoid of long-term culture-established, but they could be related to endothelial
cell lineage. Indeed, preexisting endothelial cells are initiating hematopoietic progenitors (Tavian et al., 1999).
Day 24 of development marks the appearance ofcandidates, in the trunk of vertebrate embryos, for the
generation of hematopoietic cells (Jaffredo et al., 1998; lymphoid potential inside the human embryo, whereas
the capacity to produce myeloid cells existed there atNishikawa et al., 1998). Accordingly, the CD34CD45
endothelial cells we sorted by flow cytometry from the least 5 days earlier. The absence of B cells in cultures from
earlier embryos from 19 to 23 days of gestation where wehuman embryonic AGM as well as from the yolk sac and
embryonic liver included hematopoietic progenitors at observed the development of NK and myeloid cells is
unlikely to be explained by quantitative considerations, asa high frequency, suggesting a direct filiation of HSC
from the vascular wall (E. Oberlin, personal communica- culture on MS-5 stroma is a very sensitive assay that
can drive multilineage development of single human HSCtion). Endothelial development and HSC emergence
would therefore be closely associated in both of the (Robin et al., 1999a). The 24 day limit may rather reflect
a key developmental switch, possibly provided by theearliest sites of hematopoiesis, the yolk sac and the
P-Sp/AGM. Although it is generally admitted that hema- neighboring endoderm and conferring to early progenitors
the ability to engage in lymphoid differentiation programs.topoietic and vascular developments are segregated
early in the yolk sac at the level of “hemangioblasts” In all experiments reported herein, B cell and T cell
developmental potentials were coupled. In striking con-(Choi et al., 1998), it was also hypothesized that even
once differentiated, some endothelial cells can still pro- trast, NK cell potential was dissociated from B and T cell
activity in the pre-24 day embryo and at all stages in theduce blood elements (Sabin, 1920).
We have herein defined the lineage potential of extra- yolk sac, which produced CD15 and CD56 cells but no
T or B cells. We have no functional characterization of theversus intraembryonic human blood cell progenitors.
At the fourth week of human gestation, the paraaortic CD56 cells that grew in our cultures. However, Carayol
et al. (1998) have described preferential development ofsplanchnopleura and later, the aorta, can give rise to B,
T, NK, and myeloid cells (Table 2). Despite the fact that human HSC cultured on MS-5 stroma in CD56 cells which
were endowed with natural killer cell function. Our demon-blood has been circulating for several days at these
stages, no such multilineage activity was ever detected stration of CD94 expression at the surface of a significant
proportion of CD56 cells differentiated from both extra-in our culture conditions in the associated yolk sacs,
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Figure 3. Development of Myeloid, NK, B, and T Cells from the Human P-Sp/Aorta and Yolk Sac
(A) Percent CD19 B cells (left scale), CD56 NK cells, and CD15 myeloid cells (right scale) produced by the human P-Sp/aorta dissected
at successive stages of development and cultured for several days on MS-5 stromal cells. Negative values have not been included (see Table 2).
(B) Myeloid, B, and NK cell development from 27 day YS and P-Sp. Cells cultured for 19 days on MS-5 stromal cells were stained with anti-
CD15-FITC, anti-CD19-PE, and anti-CD56-PE-CY and analyzed inside the morphology gates indicated.
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Table 3. Localization of Hematopoietic Potentials inside the
Human AGM
Embryo age
AGMCarnegie
stage Days P-Sp/aorta Mn  G So  NT
12 26–27 1/1 0/1 0/1
13 28–30 3/4 0/4 0/4
14 31 1/1 0/1 1/1
Mn, mesonephros; G, gonad; So, somatopleura; NT, neural tube.
and intraembryonic tissues has also further documented
the belonging of these cells to the NK cell lineage. Although
NK cells derive in the adult mouse bone marrow from a
clonogenic common lymphoid progenitor (CLP) that differ-
entiates into T, B, and NK lineages but not into myeloid
lineages (Kondo et al., 1997), the existence of CLP in
embryonic and fetal tissues has not yet been documented
(Akashi et al., 2000). Sanchez et al. (1994) did identify a
common progenitor for T lymphocytes and NK cells in
human prenatal life, but this cell was only described in
the second trimester thymus, that is, at a relatively late
stage, when the thymus has achieved its definitive struc-
ture and organization, and the yolk sac and blood-forming
AGM have long disappeared. On the other hand, the exis-
tence of NK/myeloid progenitors that could explain our
observations has not been documented yet. A population
of CD34CD33 cells has been identified in the human
postnatal thymus that gives rise in culture to both NK and
dendritic cells (Marquez et al., 1998). However, the ability
of these cells to give rise to other myeloid cells was not
examined by the authors, who concluded that both NK
and dendritic cells inside the thymus were branching off
the lymphoid cell lineage.
Other categories of progenitors may exist only at early
stages of ontogeny such as the B, T, and macrophage
common progenitor identified in mouse fetal liver by La-
caud et al. (1998). The existence of these progenitors may
also account for the dramatic B cell and macrophage
development observed upon culture of early mouse fetal Figure 4. Coculture over a Layer of MS-5 Stromal Cells of Territories
thymocytes on bone marrow stroma (Pe´ault et al., 1994). Dissected from a 30 Day Human Embryo
Finally, as another explanation for the development of No hematopoietic cells developed from the separated urogenital
ridge (C) or somatopleura and neural tube (B). Only the aorta gaveNK cells from the yolk sac in the absence of lymphoid
rise to hematopoietic cell colonies adhering to the stromal cell layercells, common T, B, and NK progenitors would also be
(A). The scale bars indicate 100 m.present outside the embryo but at an extremely low fre-
quency, and MS-5 would dramatically favor NK cell devel-
opment at the expense of B cell differentiation. While we pointed out inverse ratios (Figure 3B). Simultaneous B cell
and NK cell development of single progenitors seeded onhave not formally excluded this possibility yet by per-
forming clonal assays, it is less likely, since although in MS-5 has also shown that both lineages are, on average,
equally supported by this stromal cell line (Robin et al.,some instances NK cells seem to quantitatively dominate
B cells on MS-5 stroma (see Figure 3E), other experiments 1999a). Hence, the consistent absence of B lymphocytes
(C) Further identification of CD56 cells as NK cells developed in culture from the YS and aorta. Cells developed on MS-5 stroma from 32 day YS
and aorta were double stained with anti-CD56-PE-Cy5 and anti-CD94-PE and analyzed inside the same morphology gate as in (B).
(D) T cell potential of cells derived from 26 day YS and P-Sp. Cell suspensions prepared from NOD-SCID mouse embryonic thymuses cultured
organotypically 20 days earlier in the presence of cells developed on MS-5 stroma from the P-Sp and YS were stained with anti-CD8-PE and
anti-CD4-FITC, or with anti-CD45-FITC and anti-CD8-PE. Human CD45 cells were gated on forward and side scatters.
(E) Percent CD4-positive cells (including single- and double-positive cells) present in NOD-SCID mouse embryonic thymuses cultured for 22
days in the presence of human intraembryonic hematopoietic progenitors. Negative values have not been included (see Table 2).
(F) Representative FACS staining profiles of myeloid, NK, B, and T cells developed from the yolk sac and aorta of the same 31 day human embryo.
After expansion in bulk culture on MS-5 stromal layers and dissociation, cells were split and transferred to culture conditions promoting either
myeloid, B, and NK or T cell differentiation, as illustrated in Figure 1C. Analyses were performed under the same conditions as in (B) and (D).
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(Becton Dickinson). In 17 of these experiments, half of the cells werein our yolk sac MS-5 cocultures is probably not to be
used for T-lymphoid potential analysis as described below.explained by a competitive advantage of NK cells. In addi-
tion, yolk sac-derived cells never repopulated the thymus
T Cell Development in Fetal Thymus Organ Culture (FTOC)either, whereas T cell development from embryonic tissues
FTOCs were performed following standard procedures adapted by
was spectacular (see Figures 3D and 3F). Robin et al. (1999b) using NOD-SCID mouse embryonic (day 14)
We conclude, therefore, that rare pre-HSC emerge in thymic lobes. Briefly, 25 l hanging drops of complete medium
(RPMI 1640 supplemented with 10% heat-inactivated human serum,the human paraaortic mesoderm and are at the origin of
5% FCS, 5 ng/ml rh-IL2, 20 ng/ml rh-IL7, and 50 ng/ml rh-SCF)several hundred CD34-positive early hematopoietic pro-
containing 50–100,000 cells harvested from amplification culturesgenitors that are seen on the aortic endothelium from
were prepared in Terasaki plates. One fetal thymus lobe was addedday 27 of gestation. These ancestral blood-forming cells
to each drop, and plates were incubated for 48 hr. Thymus lobes
remain confined to the aorta and connected vitelline artery, were then transferred onto floating filters (Isopore membrane, 25
as neighboring kidney and gonad rudiments were always mm diameter, 0.8 m pore size; Millipore) in medium without cyto-
kines and cultured there for a further 18–22 days. Single-cell suspen-devoid of hematopoietic activity in our culture system,
sions were obtained by dissociating cultured thymus lobes with twoconfirming other recent observations in mice (Godin et al.,
needles. Each lobe was treated separately and the resulting cells1999; de Bruijn et al., 2000). We also show here that the
were stained with anti-human CD4-FITC, anti-CD8-PE, and anti-aorta, dissected from the embryo after day 40 and emptied
CD45-FITC (Immunotech).
of circulating blood, no longer gives rise to long-term he-
matopoiesis in vitro. Our present data provide direct evi- Acknowledgments
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